13th Congress of the European Hematology Association
Webcasted Presentation


Immunomodulatory drugs (IMiDs) in myelodysplastic syndromes: long-term outcome
Dr. A. List, Tampa, United States of America    - Biography
English - 2008-06-13
Topic: Myelodysplastic Syndromes
 
Speaker Disclosure
Celgene[Research Support; Consultant; Speakers Bureau]
Pharmion [Consultant; Speakers Bureau; Advisory Board]
MGI Pharma [Consultant]
  ( 38 slide(s) )